Strata Skin Sciences Return on Tangible Equity 2010-2023 | SSKN

Current and historical return on tangible equity values for Strata Skin Sciences (SSKN) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Strata Skin Sciences Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-12-31 $-0.01B $-0.00B 258.82%
2023-09-30 $-0.01B $-0.00B 140.00%
2023-06-30 $-0.01B $-0.01B 121.74%
2023-03-31 $-0.01B $-0.01B 120.00%
2022-12-31 $-0.01B $-0.00B 126.32%
2022-09-30 $-0.01B $-0.01B 350.00%
2022-06-30 $-0.01B $-0.01B -700.00%
2022-03-31 $-0.00B $-0.01B -80.00%
2021-12-31 $-0.00B $0.01B -35.29%
2021-09-30 $-0.00B $0.01B -21.05%
2021-06-30 $-0.00B $0.01B -19.51%
2021-03-31 $-0.01B $0.01B -48.78%
2020-12-31 $-0.00B $0.01B -36.36%
2020-09-30 $-0.01B $0.01B -44.44%
2020-06-30 $-0.01B $0.01B -42.55%
2020-03-31 $-0.00B $0.01B -33.33%
2019-12-31 $-0.00B $0.01B -33.33%
2019-09-30 $-0.00B $0.01B -24.49%
2019-06-30 $-0.00B $0.01B -23.08%
2019-03-31 $-0.00B $0.01B -22.22%
2018-12-31 $-0.00B $0.01B -38.10%
2018-09-30 $-0.01B $0.02B -114.29%
2018-06-30 $-0.02B $0.01B -525.00%
2018-03-31 $-0.02B $0.00B 1050.00%
2017-12-31 $-0.02B $-0.00B 466.67%
2017-09-30 $-0.02B $0.00B 300.00%
2017-06-30 $-0.01B $-0.01B 70.59%
2017-03-31 $-0.01B $-0.01B 66.67%
2016-12-31 $-0.00B $-0.01B 55.17%
2016-09-30 $-0.00B $-0.01B 53.33%
2016-06-30 $-0.01B $-0.01B 175.00%
2016-03-31 $-0.02B $-0.01B 366.67%
2015-12-31 $-0.03B $-0.01B 1600.00%
2015-09-30 $-0.03B $-0.01B -1015.38%
2015-06-30 $-0.02B $0.00B -248.65%
2015-03-31 $-0.01B $0.01B -133.33%
2014-12-31 $-0.02B $0.01B -150.00%
2014-09-30 $-0.01B $0.02B -155.56%
2014-06-30 $-0.02B $0.01B -245.16%
2014-03-31 $-0.03B $0.01B -263.41%
2013-12-31 $-0.03B $0.01B -179.31%
2013-09-30 $-0.03B $0.01B -168.75%
2013-06-30 $-0.03B $0.02B -138.89%
2013-03-31 $-0.02B $0.02B -124.32%
2012-12-31 $-0.02B $0.01B -117.33%
2012-09-30 $-0.02B $0.02B -92.31%
2012-06-30 $-0.02B $0.02B -95.65%
2012-03-31 $-0.02B $0.02B -91.67%
2011-12-31 $-0.02B $0.03B -84.85%
2011-09-30 $-0.02B $0.02B -83.17%
2011-06-30 $-0.02B $0.02B -67.23%
2011-03-31 $-0.02B $0.03B -65.57%
2010-12-31 $-0.02B $0.03B -63.49%
2010-09-30 $-0.02B $0.04B -67.74%
2010-06-30 $-0.02B $0.03B -75.00%
2010-03-31 $-0.02B $0.03B -85.11%
2009-12-31 $-0.02B $0.03B -102.70%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.018B $0.033B
Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $39.354B 21.89
Inspire Medical Systems (INSP) United States $7.194B 0.00
IRhythm Technologies (IRTC) United States $3.483B 0.00
Axonics (AXNX) United States $3.401B 0.00
10x Genomics (TXG) United States $3.288B 0.00
Enovis (ENOV) United States $3.030B 23.02
Azenta (AZTA) United States $2.910B 237.18
Olink Holding AB (publ) (OLK) Sweden $2.840B 0.00
Hims & Hers Health (HIMS) United States $2.678B 0.00
Privia Health (PRVA) United States $2.167B 96.11
Schrodinger (SDGR) United States $1.733B 0.00
Omnicell (OMCL) United States $1.279B 31.30
Phreesia (PHR) United States $1.162B 0.00
Definitive Healthcare (DH) United States $0.823B 0.00
Standard BioTools (LAB) United States $0.708B 0.00
Fulgent Genetics (FLGT) United States $0.601B 0.00
Talkspace (TALK) United States $0.527B 0.00
Health Catalyst (HCAT) United States $0.353B 0.00
Clover Health Investments (CLOV) United States $0.337B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.328B 0.00
Pulmonx (LUNG) United States $0.281B 0.00
Butterfly Network (BFLY) United States $0.162B 0.00
American Well (AMWL) United States $0.153B 0.00
MSP Recovery (LIFW) United States $0.141B 0.00
P3 Health Partners (PIII) United States $0.141B 0.00
Augmedix (AUGX) United States $0.139B 0.00
Outset Medical (OM) United States $0.124B 0.00
TruBridge (TBRG) United States $0.118B 5.03
111 (YI) China $0.086B 0.00
SHL Telemedicine (SHLT) Israel $0.082B 0.00
Future Health ESG (FHLT) United States $0.073B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.048B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.035B 0.00
Movano (MOVE) United States $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Cue Health (HLTH) United States $0.022B 0.00
Akili (AKLI) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
CareCloud (CCLD) United States $0.017B 0.00
ETAO (ETAO) United States $0.015B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00